Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy comprising JAK pathway inhibitor and rock inhibitor

Combination therapy comprising JAK pathway inhibitor and rock inhibitor

US Patent 11918581 · Granted Mar 5, 2024

Estimated economic value: $19,783,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Prevention and treatment of organ injuries2025
Treatment and prevention of nephrotoxin-induced kidney injuries2025
Treatment of hidradenitis suppurativa using JAK inhibitors2025
JAK1 pathway inhibitors for the treatment of prurigo nodularis2025
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2024
Cyclophilin inhibitors and uses thereof2024
JAK inhibitor with a vitamin D analog for treatment of skin diseases2024
Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Li2024
JAK1 pathway inhibitors for the treatment of vitiligo2024
JAK1 pathway inhibitors for the treatment of gastrointestinal disease2023
Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy2022
Treatment of hidradenitis suppurativa using JAK inhibitors2022